These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 9236572

  • 1. Pupil dilation to tropicamide is not specific for Alzheimer disease.
    Growdon JH, Graefe K, Tennis M, Hayden D, Schoenfeld D, Wray SH.
    Arch Neurol; 1997 Jul; 54(7):841-4. PubMed ID: 9236572
    [Abstract] [Full Text] [Related]

  • 2. Re-evaluation of tropicamide in the pupillary response test for Alzheimer's disease.
    Iijima A, Haida M, Ishikawa N, Ueno A, Minamitani H, Shinohara Y.
    Neurobiol Aging; 2003 Oct; 24(6):789-96. PubMed ID: 12927761
    [Abstract] [Full Text] [Related]

  • 3. Pupillary response to tropicamide in patients with Alzheimer disease.
    Loupe DN, Newman NJ, Green RC, Lynn MJ, WIlliams KK, Geis TC, Edelhauser HF.
    Ophthalmology; 1996 Mar; 103(3):495-503. PubMed ID: 8600428
    [Abstract] [Full Text] [Related]

  • 4. The mydriatic effect of multiple doses of tropicamide.
    Siderov J, Nurse S.
    Optom Vis Sci; 2005 Nov; 82(11):955-8. PubMed ID: 16317370
    [Abstract] [Full Text] [Related]

  • 5. [Hypersensitivity in the pupil dilation response to a cholinergic antagonist in patients with Alzheimer's disease and Down's syndrome].
    Kono K, Miyao M, Ishihara S, Takagi A, Ikari H, Suzuki Y, Iguchi A.
    Nihon Ronen Igakkai Zasshi; 1996 Nov; 33(11):829-34. PubMed ID: 8997102
    [Abstract] [Full Text] [Related]

  • 6. Tropicamide effects on pupil size and pupillary light reflexes in Alzheimer's and Parkinson's disease.
    Granholm E, Morris S, Galasko D, Shults C, Rogers E, Vukov B.
    Int J Psychophysiol; 2003 Feb; 47(2):95-115. PubMed ID: 12568941
    [Abstract] [Full Text] [Related]

  • 7. Effect of proparacaine on tropicamide-induced mydriasis.
    Siderov J, Chuang SM, Ian K, Prassinos G, Tziortzi E, Wong JY.
    Optom Vis Sci; 1997 Dec; 74(12):1039-43. PubMed ID: 9423996
    [Abstract] [Full Text] [Related]

  • 8. [Experience with pupil tropicamide test in Alzheimer's disease].
    Robles A, Touriño R, Sesar A, Suárez P, Noya M.
    Rev Neurol; 1996 Jan; 24(125):65-8. PubMed ID: 8852002
    [Abstract] [Full Text] [Related]

  • 9. Pupil dilation response to tropicamide: a biological test for Alzheimer's disease?
    Kurz A, Marquard R, Fremke S, Leipert KP.
    Pharmacopsychiatry; 1997 Jan; 30(1):12-5. PubMed ID: 9065964
    [Abstract] [Full Text] [Related]

  • 10. The tropicamide test in patients with dementia of Alzheimer type and frontotemporal dementia.
    Robles A, Touriño R, Gude F, Noya M.
    Funct Neurol; 1999 Jan; 14(4):203-7. PubMed ID: 10713893
    [Abstract] [Full Text] [Related]

  • 11. Receptor test (pupillary dilatation after application of 0.01% tropicamide solution) and determination of central nervous activation (Fourier analysis of pupillary oscillations) in patients with Alzheimer's disease.
    Grünberger J, Linzmayer L, Walter H, Rainer M, Masching A, Pezawas L, Saletu-Zyhlarz G, Stöhr H, Grünberger M.
    Neuropsychobiology; 1999 Jan; 40(1):40-6. PubMed ID: 10420100
    [Abstract] [Full Text] [Related]

  • 12. Response of the pupil to tropicamide is not a reliable test for Alzheimer disease.
    FitzSimon JS, Waring SC, Kokmen E, McLaren JW, Brubaker RF.
    Arch Neurol; 1997 Feb; 54(2):155-9. PubMed ID: 9041856
    [Abstract] [Full Text] [Related]

  • 13. Single dose of 1% tropicamide and 10% phenylephrine for pupil dilation.
    Ratanapakorn T, Yospaiboon Y, Chaisrisawadsuk N.
    J Med Assoc Thai; 2006 Nov; 89(11):1934-9. PubMed ID: 17205877
    [Abstract] [Full Text] [Related]

  • 14. Sector pupil dilation with phenylephrine and tropicamide.
    Chang FW, McCan TA, Hitchcock JR.
    Am J Optom Physiol Opt; 1985 Jul; 62(7):482-6. PubMed ID: 4025504
    [Abstract] [Full Text] [Related]

  • 15. Tropicamide eyedrops cannot be used for reliable diagnosis of Alzheimer's disease.
    Graff-Radford NR, Lin SC, Brazis PW, Bolling JP, Liesegang TJ, Lucas JA, Uitti RJ, O'Brien PC.
    Mayo Clin Proc; 1997 Jun; 72(6):495-504. PubMed ID: 9179132
    [Abstract] [Full Text] [Related]

  • 16. Comparative pupil dilation using phenylephrine alone or in combination with tropicamide.
    Eyeson-Annan ML, Hirst LW, Battistutta D, Green A.
    Ophthalmology; 1998 Apr; 105(4):726-32. PubMed ID: 9544648
    [Abstract] [Full Text] [Related]

  • 17. Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects?
    Litvan I, FitzGibbon EJ.
    Neurology; 1996 Nov; 47(5):1324-6. PubMed ID: 8909451
    [Abstract] [Full Text] [Related]

  • 18. A combination solution for routine pupillary dilation.
    Krumholz DM, Portello JK, Rosenfield M, Rosenbaum JD.
    Optometry; 2006 Jul; 77(7):350-3. PubMed ID: 16814239
    [Abstract] [Full Text] [Related]

  • 19. Recovery dynamics of multifocal pupillographic objective perimetry from tropicamide dilation.
    Rai BB, Sabeti F, Carle CF, Rohan EMF, Saraç Ö, van Kleef J, Maddess T.
    Graefes Arch Clin Exp Ophthalmol; 2020 Jan; 258(1):191-200. PubMed ID: 31720837
    [Abstract] [Full Text] [Related]

  • 20. Cholinergic dysfunction in cognitive impairments after aneurysmal subarachnoid hemorrhage.
    Nozaki T, Sakai N, Oishi H, Nishizawa S, Namba H.
    Neurosurgery; 2002 Oct; 51(4):944-7; discussion 947-8. PubMed ID: 12234401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.